Tenet Healthcare Corporation THC delivered second-quarter 2018 adjusted net income of 49 cents per share, outperforming the Zacks Consensus Estimate by 104.2%. The upside is primarily driven by the performance of Ambulatory Segment. Moreover, the bottom line rebounded from the year-ago loss of 17 cents.Tenet Healthcare Corporation Price and EPS Surprise Tenet Healthcare Corporation Price and EPS Surprise | Tenet Healthcare Corporation QuoteQuarterly Operational UpdateNet operating revenues came in at $4.5 billion, down 6.2% year over year. Additionally, the top line missed the Zacks Consensus Estimate by 1.6%. This was due to weak performances by the Hospital and other plus Conifer segments.Tenet Healthcare’s same-hospital exchange admissions were 4,725, down 5.6 % year over year.Same-hospital exchange outpatient visits were 51,845, up 0.6% year over year.Quarterly Segment DetailsHospital & OtherNet operating revenues in the Hospital Operations and Other segment came in at $3.7 billion, down 8.6% year over year This downside is largely attributable to hospital divestitures and a decline in health plan business.On same-hospital basis, patient revenues were $3.4 billion, up 3.2% year over year.Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) was $345 million, down 0.3% year over year.Ambulatory SegmentThe Ambulatory segment generated net operating revenues of $531 million, up 12.5% year over year.Additionally, the segment reported adjusted EBITDA of $198 million, up 20.7% year over year.Conifer SegmentConifer’s revenues decreased 3.5% from the prior-year quarter’s level to $386 million. This was mainly due to the company’s divestiture activities.The segment reported $91 million of adjusted EBITDA in the quarter under review, up 51.7% year over year.Financial PositionAs of Jun 30, 2018, Tenet Healthcare had cash and cash equivalents of $403 million, down 34% from the number at year-end 2017.The company exited the second quarter with $14.2 billion of long-term debt, down 3.4% from the count at 2017 end.Net cash provided by operating activities for the first half of 2018 stands at $461 million, up 15% year over year.2018 OutlookAdjusted earnings per share are projected between $1.54 and $1.88, up from the earlier projection of $1.36-$1.70.Tenet Healthcare retains its expectation for revenues in the range of $17.9-$18.3 billion.Adjusted EBITDA is reaffirmed between $2.55 billion and $2.65 billion.Tenet Healthcare reiterates adjusted its free cash flow of $725-$925 million. However, the company has lowered its net cash provided by operating activities from $1.245-$1.550 billion to $1.220-$1.525 billion.3Q18 GuidanceThe company now anticipates revenues in the range of $4.3-$4.5 billion, down from the earlier projection of $4.475-$4.675 billion.The company now envisions adjusted EBITDA between $575 million and $625 million, down from the previous prediction of $605-$655 million.Adjusted earnings per share from continuing operations are likely to vary between 10 cents and 24 cents, down from the past estimate of 15-29 cents.Zacks Rank and Performance of Other PlayersTenet Healthcare carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Among other players from the HMO industry having reported second-quarter earnings so far, the bottom line of Anthem Inc. ANTM, Centene Corporation CNC and UnitedHealth Group Inc. UNH beat the respective Zacks Consensus Estimate.The Hottest Tech Mega-Trend of AllLast year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.See Zacks' 3 Best Stocks to Play This Trend >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report Anthem, Inc. (ANTM): Free Stock Analysis Report Centene Corporation (CNC): Free Stock Analysis Report Tenet Healthcare Corporation (THC): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research